Efficacy of TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis

BackgroundTransarterial chemoembolization (TACE) is currently widely used in the treatment of patients with unresectable hepatocellular carcinoma. However, the combination of TACE with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) during treatment remains controversial. T...

Descripción completa

Detalles Bibliográficos

Autores principales:	Kailin Ye, Jiale Zhou, Jie Lin, Yongzhi Li, Yansong Luo, Fei Xie
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2025-12-01
Colección:	Frontiers in Oncology
Materias:	hepatocellular carcinoma TACE tyrosine kinase inhibitors immune checkpoint inhibitors meta-analysis
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1707622/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!